Hepatitis A Vaccination in Korea: Tests and Dose History
Start with the record and the reason for testing
This guide is for adults arranging care in South Korea, with sources checked on 7 October 2026. Before booking a hepatitis A antibody test, find any previous vaccination record and identify the exact test already performed. KDCA generally advises vaccination without prior antibody testing below age 40, and antibody testing followed by vaccination if susceptible at age 40 or older. A documented completed series still matters; age alone does not mean starting again. [1]
The useful first question is whether you need a first dose, a remaining dose, or a review of existing evidence. Tell the clinic which question you are trying to answer. This is more informative than asking for a generic “hepatitis shot.”
Read the full laboratory name
Normal liver enzymes do not establish immunity to hepatitis A. ALT and AST relate to liver injury, while hepatitis A antibody tests address different questions. IgG anti-HAV can indicate immunity following infection or vaccination. IgM anti-HAV is used when recent infection is suspected. Total anti-HAV combines antibody classes and cannot, by itself, date an infection. [2]
Keep the full report, including the test name, result and collection date. A screenshot containing only “positive” loses important context. Ask: “Does this result show immunity, or do I need another assessment?” Avoid ordering an acute-infection test simply because it contains the words hepatitis A.
Add your health and travel context
KDCA identifies situations such as travel to affected areas, occupational exposure, chronic liver disease and immune suppression as reasons for particular attention. Someone receiving care for hepatitis B or C may still need hepatitis A prevention. Immunity to one hepatitis virus does not establish immunity to another. [1][3]
Bring your diagnosis list and medication list to the appointment. If travel prompted the enquiry, include the destination and departure date. These details help the clinician assess urgency and whether testing would change the plan. A country-specific travel consultation may include other issues beyond this vaccine.
If you have already received a dose
Look for the product name as well as the date. An overseas record may refer to a single-antigen hepatitis A vaccine or a combined hepatitis A and B product. Their schedules should not be treated as interchangeable. Korean guidance describes a second hepatitis A dose at least six months after the first, with the appropriate interval and dose depending on the product. [1][3]
A delayed dose generally does not require restarting a valid vaccine series. Give the receiving clinic the dates and ask whether the remaining dose can be continued. An injection administered too early raises a separate minimum-interval question. Do not shorten a remaining interval to compensate for a missed appointment. [5]
For example, if you moved cities after dose one, ask the previous clinic for documentation before your new appointment. Keep an unknown product or date marked as unknown rather than filling the gap from memory.
A completed series and a new antibody test
Routine post-vaccination antibody testing is generally unnecessary for healthy people who complete the series. Testing can have a different role when immune suppression or another clinical circumstance means the result would change care. The clinician should explain the purpose of any proposed test. [3][6]
Ask whether an old report can be used, whether the clinic needs the original document, and whether a translation is necessary. Keep the original-language vaccine name with any English translation. Do not translate a brand into the name of a different product that happens to be familiar overseas.
Symptoms and recent exposure need a different appointment
Jaundice, dark urine, significant nausea or vomiting, or abdominal pain should prompt medical assessment rather than an ordinary vaccine booking. Symptoms alone cannot reliably distinguish hepatitis A from other causes of hepatitis. Severe dehydration or altered awareness warrants urgent care. [1][2]
If you have recently had contact with someone with hepatitis A, tell the clinic promptly and give the exposure date. Post-exposure prevention is time-sensitive. CDC’s United States guidance describes action as soon as possible within two weeks, with the intervention depending on age and clinical circumstances. Your Korean clinician or public health team must decide the appropriate local approach. Do not wait for a routine screening appointment before asking. [3][4]
Check practical details before attending
A useful enquiry is: “I would like a hepatitis A vaccination consultation. I have a record of one dose and a previous antibody report. Can you review these, tell me whether testing is needed, and quote the remaining vaccination and consultation costs?” In Korean, the vaccine is A형간염 예방접종 and an antibody test is 항체검사.
Confirm that the clinic provides both the requested test and the adult vaccine. Ask about stock, appointments, accepting outside results and whether you will need a return visit. Separate a per-dose price from the full cost of completing the plan. If support is advertised, ask for the applicable eligibility conditions rather than assuming that routine health insurance covers it.
Leave with a usable record
After the visit, save the product, date, provider and clinician-agreed next step. Keep the actual test report rather than a handwritten summary saying “immune.” If a decision remains pending, record what information is missing and who will review it.
This article provides general information, not an individual prescription. Decide on testing and vaccination with a clinician who can review your history, current health and the product available in Korea.
Related published guides
- Blood Test Results Explained | Lab Values, Units & Reference Ranges
- South Korea Vaccination Law 2026: What Changes and When?
Sources
- 질병관리청 예방접종도우미 A형간염 · 질병관리청 · 최종검토 2025-01-20 · 2026-10-07 KST
- Clinical Screening and Diagnosis for Hepatitis A · CDC 미국 · 공식 현행 페이지 확인 · 2026-10-07 KST
- Pink Book Chapter 9 Hepatitis A · CDC 미국 · 공식 현행 페이지 확인 · 2026-10-07 KST
- Hepatitis A Vaccine Administration · CDC 미국 · 공식 현행 페이지 확인 · 2026-10-07 KST
- Timing and Spacing of Immunobiologics · CDC 미국 · 페이지 표기 2024-07-24 · 2026-10-07 KST
- Prevention of Hepatitis A Virus Infection in the United States ACIP Recommendations 2020 · CDC 미국 ACIP · 2020-07-03 · 2026-10-07 KST
